InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the complete record of transactions filed by HULL CHARLES W, Executive. Officer active across 1 company, notably 3D SYSTEMS CORP. Cumulatively, 9 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €449k. History available since 13 December 2021. The latest transaction was disclosed on 8 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
26,386 shares@ US$10.94530.061% mcap40.9% of flowCommon StockSEC:0001209191-22-035863:0
18,137 shares0Common StockSEC:0001209191-22-019645:0
13,226 shares@ US$14.77030.041% mcap27.3% of flowCommon StockSEC:0001209191-22-017574:0
23,516 shares0Common StockSEC:0001209191-22-016780:0
2,140 shares@ US$19.380.0083% mcap5.6% of flowCommon StockSEC:0001209191-22-010848:0
3,119 shares@ US$20.180.012% mcap64.0% of flowCommon StockSEC:0001209191-22-003328
3,119 shares@ US$20.180.012% mcap8.4% of flowCommon StockSEC:0001209191-22-003328:0
1,651 shares@ US$21.330.0070% mcap4.7% of flowCommon StockSEC:0001209191-21-069773:0
1,651 shares@ US$21.330.0070% mcap36.0% of flowCommon StockSEC:0001209191-21-069773
9 of 9 declarations
About HULL CHARLES W
Charles W. Hull is Executive Vice President and Chief Technology Officer (Regenerative Medicine) of 3D Systems Corp. He leads the company's technological initiatives in the field of regenerative medicine, focusing on innovation and the development of new products.
